Lipigon Pharmaceuticals AB (publ) (LPGO.ST)

SEK 0.17

(-4.69%)

Annual Income Statements

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 16.4 Million 390 Thousand 3.18 Million 4.27 Million 1.74 Million 18 Thousand
Cost of Revenue 21.52 Million 24 Thousand 43.12 Million 11.97 Million 5.4 Million 15 Thousand
Gross Profit -5.11 Million 366 Thousand -39.94 Million -7.69 Million -3.66 Million 3000.00
Operating Expenses 7.25 Million 38.13 Million 44.37 Million 12.1 Million 6.67 Million 3.78 Million
Selling, General and Administrative Expenses - 31.65 Million 38.24 Million 8.73 Million 5.4 Million 3.08 Million
Research and Development Expenses - - - - - -
Other Expenses 7.25 Million 6.47 Million 6.12 Million 3.37 Million 1.27 Million 687 Thousand
Cost and Expenses 28.77 Million 38.13 Million 44.37 Million 12.1 Million 6.67 Million 3.78 Million
Operating Income -12.37 Million -37.74 Million -41.19 Million -7.82 Million -4.93 Million -3.76 Million
Interest Expense 3000.00 - 5000.00 3000.00 - -
Income Tax Expense - -37 Thousand 5000.00 244 Thousand 52 Thousand -161.14 Thousand
Earnings before Tax -12.12 Million -37.7 Million -41.11 Million -8.06 Million -4.98 Million -3.76 Million
Net Income -12.12 Million -37.66 Million -41.11 Million -8.31 Million -5.03 Million -3.76 Million
Earnings Per Share Basic -0.19 -2.12 -3.35 -1.38 -0.40 -0.30
Earnings Per Share Diluted -0.19 -2.12 -3.35 -1.38 -0.40 -0.30
Weighted Average Shares Outstanding 64.12 Million 17.79 Million 12.27 Million 6.01 Million 12.52 Million 12.52 Million
Weighted Average Shares Outstanding (Diluted) 64.12 Million 17.79 Million 12.27 Million 6.01 Million 12.52 Million 12.52 Million
Gross Margin -0.31 0.94 -12.56 -1.80 -2.10 0.17
EBIT Margin -0.74 -96.62 -12.92 -1.83 -2.80 -209.33
Profit Margin -0.74 -96.58 -12.93 -1.94 -2.89 -209.33
EBITDA -12.1 Million -37.68 Million -41.09 Million - - -
Earnings Before Tax Margin -0.75 -96.77 -12.95 -1.83 -2.83 -209.33

Income Statement Charts